Filing Details

Accession Number:
0001104659-23-006298
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-24 20:08:20
Reporting Period:
2023-01-20
Accepted Time:
2023-01-24 20:08:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720893 Bioxcel Therapeutics Inc. BTAI Pharmaceutical Preparations (2834) 821386754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1733272 Frank Yocca C/O Bioxcel Therapeutics, Inc.
555 Long Wharf Drive, 12Th Floor
New Haven CT 06511
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-20 50,000 $30.00 8,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1.
  2. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $30.00 to $30.03. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.